Global Ursodeoxycholic Acid Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Potential Market Growth Rate of the Ursodeoxycholic Acid Market?
The ursodeoxycholic acid market size has grown rapidly in recent years. It will grow from $0.96 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to limited production methods for ursodeoxycholic acid, reliance on animal-derived extraction, growing awareness of liver disease management, increasing hospital and specialty clinic treatments, limited research on non-alcoholic fatty liver disease.

The ursodeoxycholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.6 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to advancements in chemical and enzymatic synthesis, rising prevalence of liver and biliary diseases, expansion of specialty clinics and research institutions, increased regulatory approvals for synthetic udca, development of novel administration formulations. Major trends in the forecast period include rising prevalence of gallstones and cholestatic liver disorders, increased adoption of synthetic and biosynthetic udca, expansion of oral and intravenous administration routes, growing use in research and clinical trials for liver diseases, focus on personalized treatment and dosage optimization.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/ursodeoxycholic-acid-global-market-report

Which Major Growth Factors Are Shaping the Ursodeoxycholic Acid Market?
The rising prevalence of liver diseases is expected to propel the growth of the ursodeoxycholic acid market going forward. Liver diseases refer to various conditions that impair the liver's ability to function properly, including infections, inflammation, fatty liver, cirrhosis, and liver cancer. The rising prevalence of liver diseases is due to increasing alcohol consumption, as excessive drinking over time can lead to damage of the liver. Ursodeoxycholic acid supports liver disease treatment by improving bile flow and reducing toxic bile acids, making it effective for conditions such as primary biliary cholangitis. It enhances patient outcomes by slowing liver damage progression and aiding in cholesterol gallstone dissolution, increasing overall treatment efficiency. For instance, in April 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, there were 6,664 premature deaths from liver disease among males and 3,929 among females, marking a 22.8% increase for males and a 33.1% increase for females compared to 2023. Therefore, the rising prevalence of liver diseases is driving the growth of the ursodeoxycholic acid market.

What Segment Defines the Ursodeoxycholic Acid Market?
The ursodeoxycholic acid market covered in this report is segmented –

1) By Type: Synthetic Ursodeoxycholic Acid, Extraction Ursodeoxycholic Acid
2) By Route Of Administration: Oral, Intravenous, Subcutaneous
3) By Application: Gallstones, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Other Liver And Biliary Diseases
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Specialty Clinics, Research Institutions, Other End Users

Subsegments:
1) By Synthetic Ursodeoxycholic Acid: Chemically Synthesized Ursodeoxycholic Acid, Biosynthetic Ursodeoxycholic Acid, Enzymatically Synthesized Ursodeoxycholic Acid
2) By Extraction Ursodeoxycholic Acid: Animal-Derived Ursodeoxycholic Acid, Bile Extracted Ursodeoxycholic Acid, Natural Source Extracted Ursodeoxycholic Acid

Which Emerging Trends Are Driving the Ursodeoxycholic Acid Market?
Major companies operating in the ursodeoxycholic acid (UDCA) market are focusing on developing innovative therapies, such as bile acid derivatives, to enhance the treatment of liver diseases, particularly cholestatic liver disorders. Bile acid derivatives refer to modified forms of bile acids that are used in medical treatments to improve liver function and manage liver diseases. For instance, in November 2024, Nora Pharma Inc., a Canada-based pharmaceutical company, launched a generic version of Ursodiol (ursodeoxycholic acid) for the treatment of cholestatic liver diseases, including primary biliary cholangitis (PBC). This medication is primarily used to enhance liver function and slow the progression of liver damage, particularly when initiated early in the disease. It also aids in dissolving and preventing cholesterol gallstones by modifying bile composition and decreasing toxic bile acids.

Which Companies Are Driving Innovation in the Ursodeoxycholic Acid Market?
Major companies operating in the ursodeoxycholic acid market are Mankind Pharma Pvt. Ltd, Abbott Healthcare Pvt. Ltd., Shandong Octagon Chemicals Limited, J.S.C. Grindeks, Arch Pharmalabs, Ind Swift Laboratories Ltd., Symbiotec Pharmalab, Suzhou Tianlu Bio-pharmaceutical Co. Ltd, Zeal MediPharma, Prodotti Chimici e Alimentari S.P.A., Mitsubishi Tanabe Pharma Corporation, ICE Pharma Inc, Xi'an Tian Guangyuan Biotech Co. Ltd, Aamorb Pharmaceuticals Inc., Axplora Inc, Octavius Pharma Pvt. Ltd, Sichuan Elixir Pharmaceutical Co. Ltd, Signova Pharma Pvt. Ltd., Sinoway Industrial Co. Ltd, Valence Labs Pvt. Ltd.

Get the full ursodeoxycholic acid market report here:
https://www.thebusinessresearchcompany.com/report/ursodeoxycholic-acid-global-market-report

Which Regions Offer the Highest Potential for Ursodeoxycholic Acid Market Expansion?
North America was the largest region in the ursodeoxycholic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ursodeoxycholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn